Anatol J Cardiol. 2020; 23(2): 79-85 | DOI: 10.14744/AnatolJCardiol.2019.84782 | |||
Ratio of Fabry disease in patients with idiopathic left ventricular hypertrophy: A single-center study in TurkeyHasan Ali Barman1, Sevgi Özcan1, Adem Atıcı2, Caner Özgökçe1, Ahmet Öztürk1, Ayşegül Ezgi Kafalı3, Nafiye Emel Çakar4, Mustafa Emir Tavşanlı5, Mehmet Küçük3, Irfan Şahin6, Ertuğrul Okuyan11Department of Cardiology, Okmeydanı Training and Research Hospital; İstanbul-Turkey2Department of Internal Diseases, Okmeydanı Training and Research Hospital; İstanbul-Turkey 3Department of Child Health and Diseases Metabolism Unit, Okmeydanı Training and Research Hospital; İstanbul-Turkey 4Department of Neurology, Okmeydanı Training and Research Hospital; İstanbul-Turkey 5Department of Cardiology, İstanbul Gaziosmanpaşa Taksim Training and Research Hospital; İstanbul-Turkey 6Department of Cardiology, Bağcılar Training and Research Hospital; İstanbul-Turkey Objective: Fabry disease (FD) is a progressive, X-linked inherited disorder of glycosphingolipid metabolism which arises due to deficient or absent activity of lysosomal α-galactosidase A (α-Gal A). This may be associated with increased left ventricular (LV) wall thickness and may mimic the morphological features of hypertrophic cardiomyopathy. The purpose of this study was to define the ratio of occurrence of FD to the manifestation of unexplained left ventricular hypertrophy (LVH). Hasan Ali Barman, Sevgi Özcan, Adem Atıcı, Caner Özgökçe, Ahmet Öztürk, Ayşegül Ezgi Kafalı, Nafiye Emel Çakar, Mustafa Emir Tavşanlı, Mehmet Küçük, Irfan Şahin, Ertuğrul Okuyan. Ratio of Fabry disease in patients with idiopathic left ventricular hypertrophy: A single-center study in Turkey. Anatol J Cardiol. 2020; 23(2): 79-85 Corresponding Author: Hasan Ali Barman, Türkiye |
|